Comment
doi: 10.1016/S2352-3018(17)30204-7.
Epub 2017 Nov 30.
Prevention of HIV transmission by antiretroviral therapy
Affiliations
- PMID: 29199099
- DOI: 10.1016/S2352-3018(17)30204-7
Item in Clipboard
Comment
Prevention of HIV transmission by antiretroviral therapy
Lancet HIV.
2018 Mar.
No abstract available
Comment in
-
Language used to convey HIV infection risk is important - Authors' reply.Lancet HIV. 2018 Jun;5(6):e272. doi: 10.1016/S2352-3018(18)30105-X. Lancet HIV. 2018. PMID: 29893240 No abstract available.
-
Language used to convey HIV infection risk is important.Lancet HIV. 2018 Jun;5(6):e272. doi: 10.1016/S2352-3018(18)30103-6. Lancet HIV. 2018. PMID: 29893241 No abstract available.
Comment on
-
Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial.Lancet HIV. 2018 Mar;5(3):e116-e125. doi: 10.1016/S2352-3018(17)30205-9. Epub 2017 Nov 30. Lancet HIV. 2018. PMID: 29199100 Clinical Trial.
Similar articles
-
Ongoing challenges and recent advances in the prevention of mother-to-child transmission of HIV.J Trop Pediatr. 2013 Dec;59(6):431-3. doi: 10.1093/tropej/fmt096. J Trop Pediatr. 2013. PMID: 24287705 No abstract available.
-
[HIV, breast feeding and antiretroviral agents].Tidsskr Nor Laegeforen. 2010 Mar 11;130(5):520-2. doi: 10.4045/tidsskr.09.0933. Tidsskr Nor Laegeforen. 2010. PMID: 20224625 Norwegian. No abstract available.
-
Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.AIDS. 2008 May 11;22(8):973-81. doi: 10.1097/QAD.0b013e3282f9b67a. AIDS. 2008. PMID: 18453857
-
Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?Drug Saf. 2007;30(3):203-13. doi: 10.2165/00002018-200730030-00004. Drug Saf. 2007. PMID: 17343429 Review.
-
The impact of gender and pregnancy on antiretroviral therapy for HIV: pharmacokinetic and disease-related differences.J Gend Specif Med. 2003;6(1):7-16. J Gend Specif Med. 2003. PMID: 12661172 Review. No abstract available.
Cited by
-
The HIV/AIDS pandemic will not end by the year 2030 in low and middle income countries.Pan Afr Med J. 2019 Feb 7;32:67. doi: 10.11604/pamj.2019.32.67.17580. eCollection 2019. Pan Afr Med J. 2019. PMID: 31223359 Free PMC article.
-
Nationwide Study of Drug Resistance Mutations in HIV-1 Infected Individuals under Antiretroviral Therapy in Brazil.Int J Mol Sci. 2021 May 18;22(10):5304. doi: 10.3390/ijms22105304. Int J Mol Sci. 2021. PMID: 34069929 Free PMC article.
-
Safety and Pharmacokinetic Profiles of Long-Acting Injectable Antiretroviral Drugs for HIV-1 Pre-Exposure Prophylaxis: A Systematic Review and Meta-analysis of Randomized Trials.Front Pharmacol. 2021 Jul 7;12:664875. doi: 10.3389/fphar.2021.664875. eCollection 2021. Front Pharmacol. 2021. PMID: 34305587 Free PMC article.
-
Opportunities and Challenges in HIV Treatment as Prevention Research: Results from the ANRS 12249 Cluster-Randomized Trial and Associated Population Cohort.Curr HIV/AIDS Rep. 2020 Apr;17(2):97-108. doi: 10.1007/s11904-020-00487-1. Curr HIV/AIDS Rep. 2020. PMID: 32072468 Free PMC article. Review.
-
Safety and Efficacy of Long-Acting Injectable Agents for HIV-1: Systematic Review and Meta-Analysis.JMIR Public Health Surveill. 2023 Jul 27;9:e46767. doi: 10.2196/46767. JMIR Public Health Surveill. 2023. PMID: 37498645 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
